Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
For clinician-directed use
Phase 1 human trials have been registered in some geographies Published human efficacy data at the level of a completed, results-reported phase 2 study are not yet a settled part of the dataset Commercial development is active but has not produced a near-term approval path Patients and clinicians tracking 5-amino-1MQ should monitor ClinicalTrials.gov and peer-reviewed publications for current status
Schilling Test The flushing dose is 1,000 mcg
Regenerative Medicine and Anti-Aging Applications Some healthcare practitioners have begun integrating BPC-157 and TB-500 into regenerative medicine and anti-aging treatment protocols, despite the limited clinical evidence supporting these uses
US$ 27.01
US$ 29.93
US$ 27.65
